Today, Syngenta announced that it has acquired the Novartis repository of natural compounds and genetic strains for agricultural use, while Novartis maintains exclusive rights to repository for pharmaceutical use. The transaction also includes transfer of the Novartis Natural Products and Biomolecular…Original Article